Supporting Biotechnology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Labcorp (NYSE: LH) (the “Company”), a leading global life sciences company, today announced that its Board of Directors has authorized the Company to pursue a spin-off of the Company’s wholly owned Clinical Development business to Labcorp shareholders through a tax-free transaction. The planned spin-off will ...

Press release content from Business Wire. The AP news staff was not involved in its creation.